Effects of Sample Storage Conditions on Glycated Hemoglobin Measurement: Evaluation of Five Different High Performance Liquid Chromatography Methods

2007 ◽  
Vol 9 (1) ◽  
pp. 36-42 ◽  
Author(s):  
Randie R. Little ◽  
Curt L. Rohlfing ◽  
Alethea L. Tennill ◽  
Shawn Connolly ◽  
Steve Hanson
1992 ◽  
Vol 54 (4) ◽  
pp. 789-790 ◽  
Author(s):  
Shinogu HASEGAWA ◽  
Toshinori SAKA ◽  
Naoyuki TAKEMURA ◽  
Hidekazu KOYAMA ◽  
Shigekatsu MOTOYOSHI

1991 ◽  
Vol 53 (1) ◽  
pp. 65-68 ◽  
Author(s):  
Shinogu HASEGAWA ◽  
Toshinori SAKO ◽  
Naoyuki TAKEMURA ◽  
Hidekazu KOYAMA ◽  
Shigekatsu MOTOYOSHI

2021 ◽  
Vol 26 (3) ◽  
pp. 265-270
Author(s):  
Jesse Cramer ◽  
Mackenzie Bevry ◽  
Stephanie Handler ◽  
Kathryn Tillman ◽  
Ehab A. Abourashed

OBJECTIVE Ambrisentan, an endothelin receptor antagonist FDA-approved for the treatment of pulmonary arterial hypertension in adult patients, lacks an acceptable pediatric dosage form. The objective of this investigation was to determine the stability of an extemporaneously compounded ambrisentan suspension. METHODS Ambrisentan suspension was compounded to a concentration of 1 mg/mL using commercially available suspending agents. The suspension was then evenly split into 2 plastic amber prescription bottles. One bottle was stored at room temperature and under continuous fluorescent light while the other bottle was stored under refrigeration and protection from light. A fast and selective reversed-phase high-performance liquid chromatography (HPLC) method was developed and validated for the analysis of ambrisentan. HPLC analysis was performed on samples withdrawn from the stock bottles at predetermined time intervals, up to 90 days. RESULTS The developed HPLC method enabled the elution and detection of ambrisentan peak at 4.4 minutes. HPLC analysis revealed that all samples from both storage conditions retained >90% potency throughout the study timeframe. There were no signs of any ambrisentan breakdown products on HPLC analysis. Color and odor of the final product was also consistent throughout the 90-day storage period. CONCLUSION Ambrisentan suspension, compounded to 1 mg/mL, is stable at room temperature or under refrigeration for up to 90 days.


1998 ◽  
Vol 274 (1) ◽  
pp. 105-109 ◽  
Author(s):  
Lucia S Parentoni ◽  
Eliana C de Faria ◽  
Maria José L.F Bartelega ◽  
Valéria M.S Moda ◽  
Ana Candida C Facin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document